Previous Close | 15.03 |
Open | 15.02 |
Bid | 14.96 x 100 |
Ask | 15.05 x 100 |
Day's Range | 14.99 - 15.03 |
52 Week Range | 11.53 - 15.89 |
Volume | |
Avg. Volume | 141,696 |
Market Cap | 217.977M |
Beta (5Y Monthly) | 1.43 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 13, 2019 |
1y Target Est | N/A |
Key Insights Significantly high institutional ownership implies Merrimack Pharmaceuticals' stock price is sensitive to...
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Key Insights Significant control over Merrimack Pharmaceuticals by retail investors implies that the general public has...